HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Andrew Frost Selected Research

Immunotherapy

6/2004Neutralizing tumor necrosis factor activity leads to remission in patients with refractory noninfectious posterior uveitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Andrew Frost Research Topics

Disease

1Radiculopathy (Radiculopathy, Cervical)
01/2016
1Spinal Cord Diseases
01/2016
1Osteolysis
03/2012
1Inflammation (Inflammations)
06/2004
1Posterior Uveitis
06/2004
1Macular Edema
06/2004

Drug/Important Bio-Agent (IBA)

1poly(lactide) (polylactic acid)IBA
03/2012
1Proteins (Proteins, Gene)FDA Link
06/2004
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
06/2004
1Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA
06/2004

Therapy/Procedure

1Diskectomy (Discectomy)
01/2016
1Telescopes
06/2004
1Intravenous Infusions
06/2004
1Therapeutics
06/2004
1Immunotherapy
06/2004